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1 Present address.a b s t r a c t
We have recently shown that nc886 (pre-miR-886 or vtRNA2-1) is not a genuine microRNA precursor
nor a vault RNA, but a novel type of non-coding RNA that represses PKR, a double-stranded RNA
(dsRNA) dependent kinase. Here we have characterized their direct physical association. PKR’s
two RNA binding domains form a speciﬁc and stable complex with nc886’s central portion, without
any preference to its 50-end structure. By binding to PKR with a comparable afﬁnity, nc886 competes
with dsRNA and attenuates PKR activation by dsRNA. Our data suggest that nc886 sets a threshold
for PKR activation so that it occurs only during genuine viral infection but not by a minute level
of fortuitous cellular dsRNA.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction signiﬁcance as a tumor suppressor through its ability to repressDuring the last decade regulatory roles of RNA have drawn
signiﬁcant attention. Small regulatory non-coding RNAs (ncRNAs),
microRNAs (miRNAs) as a representative class, regulate target mes-
senger RNAs (mRNAs) through RNA–RNA interactions. Albeit not as
extensively studied as miRNAs, a handful of ncRNAs have been
shown to modulate target proteins through RNA–protein interac-
tions (reviewed in [1]). Our laboratory has recently added nc886
(pre-miR-886 or vtRNA2-1) to this list. Although its aliases imply
that it is either a miRNA precursor or a vault RNA (vtRNA) in the
vault complex, we have demonstrated that nc886 is neither a
canonical miRNA nor a vtRNA and thus it has been renamed nc886
(non-coding RNA-886). Rather, we have identiﬁed nc886 as a 101-
nt (nucleotide) long ncRNA that represses PKR (Protein Kinase
RNA-activated) [2]. A recent report has noted nc886’s biologicalchemical Societies. Published by E
tase; dsRBM, dsRNA binding
horetic mobility shift assays;
icroRNA; nc886, non-coding
Kinase RNA-activated; PNK,
ingle-stranded RNA; vtRNA,PKR [3].
PKR, an interferon-inducible and double-stranded RNA (dsRNA)
dependent kinase, plays a critical role in the host defense against
viral infection (reviewed in [4]). Upon sensing dsRNA, PKR dimer-
izes and undergoes autophosphorylation. The phosphorylated form
of PKR, now as an active kinase, phosphorylates its downstream
substrates and mediates the anti-viral response. As PKR preferen-
tially binds to genuine dsRNA or single-stranded RNA (ssRNA) with
an extensive hairpin structure, PKR has been thought to recognize
mainly dsRNA motifs (reviewed in [5]).
We have shown that when nc886 is in physical association with
PKR, repression occurs [2]. Depletion of nc886 leads to PKR activa-
tion in the absence of exogenous dsRNA, which is likely due to
PKR’s high afﬁnity for cellular dsRNA that exists at a basal level.
As PKR activation by exogenous dsRNA during viral infection is a
more natural situation (reviewed in [4]), we questioned if repres-
sion of PKR by nc886 is effective also in this context. A key to that
answer is the molecular mechanism of how nc886 represses PKR. Is
it through their direct binding? If so, it is likely that dsRNA is dom-
inant over nc886, because it is less likely that nc886 would be able
to compete with dsRNA for PKR binding. Alternatively, does nc886
recruit PKR and other factors to form a stable nucleoprotein
complex which sequesters PKR therein? In this scenario, it islsevier B.V. All rights reserved.
Fig. 1. nc886 inhibits PKR activation by dsRNA and the subsequent interferon response. (A) Northern hybridization showing nc886 in indicated cell lines. EtBr (ethidium
bromide) staining of total RNA is shown for equal loading. (B and C) Western blotting detection of indicated proteins (panel B) and densitometer quantiﬁcation (panel C) after
transfection of PolyI:C. Each was quantiﬁed with AlphaView software 2.0.1.1 (Alpha Innotech) and the level of phospho-PKR relative to total PKR was plotted. (D) Interferon-b
(INF-b) promoter activity after mock transfection (‘‘none’’ in x-axis) and transfection of PolyI:C.
3478 S.H. Jeon et al. / FEBS Letters 586 (2012) 3477–3484possible that PKR stays in the repressed state, even when an excess
amount of exogenous dsRNA challenges.
To address these issues, we examined PKR activation by dsRNA
in cells and performed in vitro RNA–protein binding experiments.
Our in vitro binding data have provided an answer to explain our
cellular data. Furthermore, characterization of nc886–PKR interac-
tion and its comparison to other PKR ligands have yielded intrigu-
ing results that revealed a new feature of PKR binding to RNA.
2. Materials and methods
2.1. Cell lines, antibodies, RNA, plasmid DNAs, and luciferase assays
pLPCX-pre-886 and its parental vector pLPCX-U6 were stably
integrated into 293T cells to yield 293T:886 and 293T:vector
respectively [2]. PolyI:C-LMW (low molecular weight: 0.2–1 kb)Fig. 2. Direct binding of PKR domains to nc886 in EMSA. (A) A schematic diagram depic
NP_002750.1. (B) Coomassie blue staining of indicated PKR domains (black bars in panel A
the right. (C) EMSA gels with indicated PKR domains and RNA probes. One hundred nan
EMSA gels with titrating amount of PKR domains on nc886 probe.was purchased from InvivoGen (San Diego, CA) and transfected
at a concentration of 1 lg/ml with Lipofectamine™ 2000 reagent
(Invitrogen, Carlsbad, CA) per the manufacturer’s instructions.
pIFNb-Luc (interferon-b promoter inserted into pGL3-basic vector)
was used in luciferase assays. All other protocols and the sources of
antibodies were as described in [2].
2.2. Cloning and puriﬁcation of dsRBMs of PKR
The construction of dsRBMs (indicated by black bars in Fig. 2A)
was based on [6]. DNA fragments for the dsRBMs were PCR-ampli-
ﬁed on pcDNA3-PKR-HA (a kind gift from Dr. Byung-Yoon Ahn at
Korea University, Korea). The PCR products were cloned into the
pET-23a plasmid (Novagen, Gibbstown, NJ) for the expression of
hexahistidine-tagged dsRBMs. The dsRBM1-2(K64E) was con-
structed by site-directed mutagenesis. These dsRBMs wereting PKR domains used in this study. All numbers are amino acid coordinates from
) puriﬁed from E. coli. The molecular size markers in kilodalton (kD) are indicated on
ograms of each proteins was used and RNA probes are indicated at the bottom. (D)
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side for 4 h and puriﬁed on a Ni–NTA column (Qiagen, Valencia, CA)
according to themanufacturer’s instructions. Puriﬁed proteinswere
visualized by Coomassie blue staining on a 15% SDS–polyacrylamide
gel. The dsRBM bands were quantiﬁed with AlphaView software
2.0.1.1 (Alpha Innotech, now ProteinSimple, San Leandro, CA) and
their concentrations were adjusted so that the same amounts were
used in the EMSA (electrophoretic mobility shift assays).
2.3. EMSA
Synthetic nc886 and vtRNA1-1 for EMSA templates were pre-
pared by in vitro run-off transcription with a-32P-CTP, as described
in [2]. Prior to EMSA reactions, they were denatured by heating at
85 C for 5 min followed by quick cooling on ice. dsRNA was pre-
pared by annealing of sense/antisense vtRNA1-1 by heating at
85 C for 5 min followed by slow cooling. Puriﬁed RNAs (25 ng)
and proteins were mixed in 20 ll EMSA buffer (20 mM Tris–HCl
pH 7.4, 10% glycerol, 100 mM KCl, 2 mM EDTA, 40 units RNase
inhibitor, 2.5 lg tRNA, 2 lg bovine serum albumin) and incubate
for 5 min on ice. The samples were electrophoresed on a 10%
non-denaturing polyacrylamide gel. The gel was dried and visual-
ized by autoradiography.
2.4. Binding experiments using surface plasmon resonance (Biacore)
Binding experiments were performed in a Biacore T100 using
HBS-N (10 mM HEPES pH 7.4 and 150 mM NaCl) as the running
buffer. Biotinylated nc886, made by in vitro transcription using
Biotin-16-UTP [2], was immobilized onto a SA (streptavidin) chip.
The PKR domains and competitor RNAs were diluted in HBS-NFig. 3. Biacore analyses of nc886–PKR interaction. (A) Sensogram of each PKR domains (
time (x-axis). Injection started at 0 s and ended at 60 s. Max RU (maximal response unit
with dsRBM1-2(wt) with Biacore analysis. The curves were best ﬁtted to a ‘two-state reand injected at a ﬂow rate of 30 ll/min for 60 s. After each run,
the chip was regenerated with a 15 s injection of 0.2% SDS.
2.5. RNase protection assay
RNaseA/T1 mixture and RNaseV1 were purchased from Applied
Biosystems/Ambion (Carlsbad, CA), and RNaseIf was fromNew Eng-
land Biolabs (Ipswich, MA). Synthetic nc886 for this assay was pre-
pared through the following steps: in vitro transcribed nc886 was
treated by calf-intestinal alkaline phosphatase (CIP) and then was
50-end labeled with c-32P-ATP by polynucleotide kinase (PNK).
50-32P-nc886 was gel-isolated and used. For PKR binding prior to
RNase digestion, 50-32P-nc886 in 8 ll EMSA buffer was incubated
with 100 ng of dsRBM1-2(wt) at 25 C for 10 min. RNases were
pre-diluted in EMSA buffer to folds indicated in Fig. 6. A digestion
reaction was performed with 1 ll of RNase at 25 C for 60 s and
was quenched by adding 8 ll of Gel Loading Buffer II (Applied Bio-
systems/Ambion). The digested productswere resolved by 8% dena-
turing polyacrylamide gel electrophoresis. For comparison, a
dideoxy sequencing reactionwas performed using Sequenase Quick
Denature Plasmid DNA Sequencing Kit (Affymetrix, Santa Clara, CA)
with 50-32P-primer (50-CGGGTCGGAGTTAGCTCAAGCGG-30; corre-
sponding to the 5’-end of nc886) and was run in parallel.
3. Results
3.1. nc886 inhibits PKR activation by dsRNA
To examine the effect of nc886 on PKR in the presence of dsRNA,
synthetic dsRNA PolyI:C was transfected into 293T:vector (a con-
trol kidney epithelial cell line lacking nc886) and 293T:886 (aleft panel), indicating their binding [expressed in RU (response unit) – y-axis] along
) was calculated by averaging RU values through 50–59 s (right panel). (B) Titration
action’ mechanism using Biacore T100 Analysis Software.
Fig. 4. Competition of various RNA ligands for PKR binding. (A–C) Sensogram of 4 ng/ll of dsRBM1-2(wt) with indicated competitors. All other descriptions are the same as in
Fig. 3. (D) From each sensogram, Max RU values were calculated by averaging RU values through 57–59 s and were plotted against competitor concentrations. From a
regression line, IC50 (a concentration of a competitor that inhibited Max RU reduced to 50%) was calculated. (E and F) EMSA gels of nc886 (panel E) and dsRNA (panel F), with
indicated competitors. All other descriptions are the same as in Fig. 2C and D.
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signiﬁcantly attenuated the activation of PKR and the subsequent
induction of interferon response, as seen by the decrease of phos-
pho-PKR (Fig. 1B and C) and interferon-b (IFN-b) promoter activity
(Fig. 1D).
3.2. PKR directly binds to nc886
As elaborated in Section 1, we posited two models for nc886–
PKR association – direct binding versus sequestration. Although
Fig. 1 data were less supportive of the ‘‘direct binding’’ model,
we ﬁrst examined whether PKR could directly interact with
nc886. PKR possesses two dsRNA binding motifs: dsRBM1 and 2
in its N-terminus (Fig. 2A). We puriﬁed these domains (depicted
in Fig. 2A; horizontal black bars) from E. coli (Fig. 2B) and per-
formed EMSA with in vitro transcribed RNAs. The PKR domains
bound to nc886 as well as a positive control dsRNA, but not to
vtRNA1-1 (Fig. 2C). This result was in agreement with our previous
data in which PKR was co-immunoprecipitated with nc886, but not
with vtRNA1-1 [2].
Notably, free nc886 had two forms: one slowly migrating and
the other fast migrating (respectively designated ‘‘active’’ and ‘‘in-
ert’’ in Fig. 2) in native gel electrophoresis. We gel-isolated them,
cloned them through miRNA cloning procedures (adaptor ligation,
cDNA synthesis, and PCR ampliﬁcation), and conﬁrmed that these
two forms were of identical sequence (data not shown). It was
the slowly migrating form that preferentially bound nc886. It is
also noteworthy that free vtRNA1-1 had only one form that mi-
grated similarly to ‘‘nc886(inert)’’ under the same conditions. Be-
tween nc886 and vtRNA1-1, their nucleotide lengths (99 and 101
nts, respectively) are similar and no marked differences in their
secondary structures were to be found in the Mfold analysis
(http://mfold.rna.albany.edu/) (Fig. S1).3.3. Requirements of PKR for its speciﬁc interaction with nc886
In EMSA gels, wildtype (wt) dsRBM1-2 bound to nc886 and gen-
erated sharp bands (‘‘complex-S1 and -S2’’ in Fig. 2C and D), which
were clearly distinct from the fuzzy bands yielded by individual
dsRBMs (dsRBM1 or dsRBM2) (‘‘complex-NS’’ in Fig. 1C and D).
The diffused bands reﬂected continuous association/dissociation
between nc886 and individual dsRBMs during their migration in
the EMSA gels. The unstable interaction seemed to be sustained
by a so-called ‘‘caging effect’’ that the gel matrix concentrates pro-
tein molecules around nucleic acids and prevents them from dif-
fusing away. So, individual dsRBMs bound to nc886 less stably
than dsRBM1-2(wt).
Our titration experiments indicated that the fuzzy bands repre-
sented poorly deﬁned complexes. In the case of dsRBM1-2(wt), two
discrete bands (complex-S1 and -S2) appeared sequentially as its
concentrations increased (right panel in Fig. 2D). In contrast,
migration of complex-NS was gradually shifted, but none of the
bands persisted stably during the titration of dsRBM1 (compare
lane 2–4 in the left panel of Fig. 2D). It is likely that multiple mol-
ecules of dsRBM1 aggregated around nc886 to form poorly deﬁned
complexes.
The requirement for both dsRBMs for stable interaction was
reinforced by the dsRBM1-2(K64E) construct which has a mutation
in dsRBM1 that is known to abrogate its binding capability [7].
Binding of dsRBM1-2(K64E) resulted in the shift of bands at posi-
tions similar to complex-S1 and -S2; however, the bands were
signiﬁcantly more diffused (middle panel in Fig. 2D). Like
dsRBM1-2(wt), one or two molecules of dsRBM1-2(K64E) seemed
to make contact with nc886, but not as stably as the wildtype,
due to the inactivating mutation in dsRBM1.
Compelling evidence was additionally provided by the
Biacore experiments (Fig. 3). Whereas individual dsRBMs or
Fig. 5. Competition for PKR by tri-, de-, or mono-phosphorylated nc886. Sensograms (panel A–C) and a graph plotting Max RU values against competitor concentrations
(panel D) are shown. All descriptions are the same as in Fig. 4.
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[Max RU (maximum response unit) < 10], dsRBM1-2(wt) bound
with a high afﬁnity (Max RU > 100, KD value = 12.3 nM).
We conclude that both dsRBMs are necessary to bind nc886.
The requirement of two dsRBMs has also been reported previously
[8–11]. It seemed that a single dsRBM (dsRBM1 or 2) could make
contact with nc886; however, this contact was neither deﬁned
nor stable. Presumably, two tandem dsRBMs within a PKR mole-
cule make two contacts simultaneously or sequentially, and these
two contacts provide correct positioning of PKR on nc886 for high-
afﬁnity binding. A similar model was suggested for PKR–dsRNA
interaction [12].
3.4. Binding afﬁnity and speciﬁcity of PKR to nc886
Given that a signiﬁcantly long dsRNA region was not seen in
nc886’s secondary structure (Fig. S1A), it was surprising that PKR’s
KD value for nc886 was at a nanomolar level and comparable to KD
for dsRNA [11] or other RNAs with a nearly dsRNA structure [13].
This was also evidenced by our EMSA gels in which dsRBM1-
2(wt) bound similarly to nc886 and dsRNA (Fig. 2C).
To compare various PKR ligands more quantitatively, we per-
formed competition experiments using Biacore analysis (Fig. 4A–
D). We titrated each competitor RNA and calculated concentrations
that inhibit the Max RU to 50% (IC50 values) from the data.
Whereas yeast tRNA and vtRNA competed nc886 poorly (Fig. 4A,
B and D), Poly(I:C) competed nc886 efﬁciently (IC va-
lue = 0.158 ng/ll in Fig. 4C and D) as expected. Notably, nc886’s
IC value (0.486 ng/ll) was slightly (three-fold) higher than thatof Poly(I:C), indicating these two RNAs had comparable afﬁnities
for PKR binding. In agreement with their IC50 values in Biacore,
25–50 ng of Poly(I:C) and 100 ng of nc886 reciprocally competed
each other in EMSA gels (Fig. 4E and F).
In summary, nc886 binds PKR as avidly as dsRNA. Furthermore,
nc886’s capability to compete with dsRNA explains how nc886
attenuated dsRNA-induced PKR activation in our earlier data
(Fig. 1).
3.5. The effect of the 50-end structure of nc886 on PKR binding
PKR has been shown to recognize 50-triphosphorylated ssRNA.
The synthetic nc886 used in this study was made by in vitro tran-
scription and thus was 50-triphosphorylated (50-PPP). Since we
have shown that cellular nc886 is 50-monophosphorylated (50-P)
[2], we wanted to test whether nc886–PKR binding in Figs. 2–4
was due to its unnatural 50-end. We prepared 50-tri-, de-, or
mono-phosphoryated nc886 (PPP-886, OH-886, and P-886 respec-
tively) through sequential treatments of CIP and PNK. In competi-
tion experiments using Biacore analysis, all three versions of nc886
had similar IC50 values (Fig. 5), indicating that nc886 bound PKR
irrespective of its 50-end structure.
3.6. Identiﬁcation and characterization of PKR binding sites in nc886
To further characterize nc886–PKR interaction, we performed
RNase protection assays (Fig. 6). RNaseV1 preferentially digests
based-paired nucleotides; RNaseA/T1 and RNaseIf cleaves nucleo-
tides in a single-stranded region. 50-end labeled nc886 was
Fig. 6. RNase protection assays. Treatment conditions are designated on the top of each lane. Leftmost lane is 50-32P-labeled Decade™ markers (Applied Biosystems/Ambion)
and their molecular sizes in nts are shown on the left. Rightmost four lanes are dideoxy sequencing. When identifying cleaved nts in the nc886 sequence, Decade™ markers
were mainly used as a ruler, rather than the dideoxy sequencing DNA bands that migrate differently from RNA in a denaturing gel. Arrowheads indicate RNaseA/T1 and
RNaseIf sensitive sites; diamonds, RNaseV1 sensitive sites; lines, arrays of sensitive sites; square brackets, PKR protection sites; an asterisk, nc886’s intrinsically fragile site.
The size of symbols and the thickness of lines roughly reﬂected the degree of signal. These data are summarized in Fig. 7A.
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RNaseIf treatment revealed strong cleavage regions at nts 40–42
and 51–62, together with a weak cleavage region at nts 32–37
and a few other sensitive nts. The region at nts 51–62 contained
RNaseA/T1 sensitive sites, reinforcing that this region is single-
stranded. Paradoxically, RNaseV1 sensitive sites (at nt 35–40 and
50–55) overlapped with RNaseIf sites, implying that nc886 existed
in multiple forms with two or more secondary structures. It is
worth noting that free nc886 existed in two forms in the EMSA gels
(Fig. 2).
The RNaseIf digestion pattern indicated that PKR bound nc886
at its central region (square brackets in Figs. 6 and 7A). Notably,
the nucleotide sequence in this region is divergent from vtRNA1-1, a poor PKR ligand (see Fig. 7A for comparison). Mfold prediction
of nc886’s central region (nts 30–64) revealed a base-paired seg-
ment involving nts 38–41 and 51–54 (Fig. 7B); however, 4 nt pair-
ing is so short that its signiﬁcance is questionable. Indeed, this
region was sensitive to both RNaseIf and RNaseV1, indicating that
two structures (structures I and II depicted in Fig. 7B) co-existed.
Next we attempted to distinguish nc886’s two structures, and
for this, tested nc886 mutants. Mutation of nc886 at nts 46–56 sig-
niﬁcantly weakened its binding to PKR (approximately six-fold in
Fig. 7C; see also Fig. S2), demonstrating that this region was critical
to PKR binding. Furthermore, PKR binding was not affected by
mutation at nts 39–40 that would have disrupted the short base-
paired segment. Thus, it was likely that PKR recognized structure
Fig. 7. Requirement of nc886 sequence for PKR binding. (A) Summary of Fig. 6 data. All symbols were used consistently with Fig. 6. Sequence alignment between nc886 and
vtRNA1-1 is shown in the middle. nc886 mutants are depicted, with mutated sequences (bold italic) highlighted by grey shadow. (B) Two possible structures of PKR binding
region in nc886. Mutated sequences are in bold italic. (C) Comparison of nc886 mutants in Biacore competition experiments. Sensograms are shown in Fig. S2. All other
descriptions are the same as in Fig. 4D.
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PKR binding.
4. Discussion
In this report, we have demonstrated that nc886 efﬁciently
competes with dsRNA for PKR binding and thereby inhibits the
interferon response. We have also characterized nc886–PKR inter-
action in detail. Brieﬂy, PKR’s two dsRBMs recognized single-
stranded nucleotides in nc886’s central region in a manner
independent of its 50-end structure.
4.1. Comparison among PKR ligands
The most intriguing observation in this report is nc886’s high
afﬁnity to PKR, despite its secondary structure deviation from
typical PKR ligands. PKR is a dsRNA binding protein that mainly
recognizes 20-OH groups along a dsRNA structure [8,12] without
any base speciﬁcity. Indeed, extensive duplex regions (>10 nt
based paired consecutively) are a consensus feature of secondary
structures of well-known PKR ligands. Such examples of
‘‘canonical’’ PKR ligands include VAI (virus-associated RNAI of
adenovirus type 2) [14] and HIV TAR element [15] (see Fig. S3
for their predicted secondary structures and Table S1 for
summary).
On the other hand, PKR binds to various RNAs without an exten-
sive duplex region, for instance, EBER 1 and 2 (Epstein-Barr virus
small RNA) (Fig. S4 and Table S1) [16], RNA aptamers screened
for PKR [17], and 30-UTR of a-tropomyosin mRNAs [18]. nc886’ssecondary structure (Fig. S1) unequivocally indicates that it is such
a ‘‘non-canonical’’ ligand. We speculate that nc886 or other non-
canonical ligands recognize PKR via a totally different mecha-
nism(s). We are currently investigating the structural nature of
‘‘nc886(active)’’.
4.2. What is the biological signiﬁcance of nc886–PKR interaction?
nc886 is ubiquitously expressed in human cells [2]. Usually,
viruses express their own ncRNAs that repress PKR as a mechanism
to bypass the host defense system [19]. Then, why do human cells
express nc886 that may disarm them? We suggest that nc886 sets
a threshold for PKR activation, ensuring its activation only when
viruses indeed infect. As discussed earlier, PKR is activated not only
by bona ﬁde dsRNAs, but also by diverse RNA species. Without
nc886, PKR might be activated by sensing a basal-level amount
of such RNAs, leading to fatal effects on cells.
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